User: Guest  Login
Document type:
Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't; Letter
Author(s):
Ferrero, S; Pastore, A; Scholz, C W; Forstpointner, R; Pezzutto, A; Bergmann, L; Trümper, L; Finke, J; Keller, U; Ghione, P; Passera, R; Hiddemann, W; Weigert, O; Unterhalt, M; Dreyling, M
Title:
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
Journal title abbreviation:
Leukemia
Year:
2016
Journal volume:
30
Journal issue:
4
Pages contribution:
984-7
Language:
eng
Fulltext / DOI:
doi:10.1038/leu.2015.215
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/26242461
Print-ISSN:
0887-6924
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX